Bloodstream Infection and Colorectal Cancer Risk in Queensland Australia, 2000-2019.
Kevin B Laupland, Felicity Edwards, Luis Furuya-Kanamori...
https://pubmed.ncbi.nlm.nih.gov/37230400Actively Recruiting
Led by Odense University Hospital · Updated on 2025-11-18
100
Participants Needed
1
Research Sites
30 weeks
Total Duration
Researchers are studying colorectal cancer and precancerous tumors in adults hospitalized with blood stream infections caused by anaerobic gut-associated bacteria. The study aims to find out how common cancer and precancerous tumors are in the large intestines and rectum among these patients. This observational study is led by Odense University Hospital and focuses on diagnosing these conditions after infection. Participants will be offered a colon capsule endoscopy using the PillCam Colon 2 device about 4 to 8 weeks after they are discharged from the hospital. This involves swallowing a small camera in a pill form that takes images of the colon to help detect tumors or cancerous growths. The study does not involve any treatment but focuses on screening and diagnosis. During the study, participants will undergo this colon capsule endoscopy examination and researchers will track the presence of colorectal cancer and precancerous tumors within 4 to 8 weeks after hospitalization. Participants must be able to give consent and communicate in Danish. The study monitors safety by excluding those with certain medical conditions or previous surgeries and collects data to better understand cancer prevalence in this patient group.
CONDITIONS
Examination of the Large Intestine With Camera Capsule in Patients With Blood Stream Infection With Gut-associated Bacteria
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 4 to 8 weeks after hospitalization
Participants undergo colon capsule endoscopy to screen for colorectal cancer and precancerous tumors.
1 visit (in-person)
Total: 1 location
1
Odense University Hospital
Odense, Denmark, 5000
Actively Recruiting
C
Charlotte Nielsen Agergaard, MD
M
Mark Bremholm Ellebæk, Professor
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Kevin B Laupland, Felicity Edwards, Luis Furuya-Kanamori...
https://pubmed.ncbi.nlm.nih.gov/37230400Ulrik S Justesen, Stig L Nielsen, Thøger G Jensen...
https://pubmed.ncbi.nlm.nih.gov/35380653Ulrik S Justesen, Mark B Ellebæk, Niels Qvist...
https://pubmed.ncbi.nlm.nih.gov/38960102